Integer (NYSE:ITGR – Get Free Report) released its quarterly earnings results on Thursday. The medical equipment provider reported $1.43 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.07, Briefing.com reports. The company had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.27 earnings per share. Integer updated its FY24 guidance to $5.24-5.43 EPS and its FY 2024 guidance to 5.240-5.430 EPS.
Integer Price Performance
Shares of ITGR stock opened at $125.82 on Friday. The stock has a market cap of $4.22 billion, a price-to-earnings ratio of 43.54, a PEG ratio of 1.86 and a beta of 1.08. The business’s fifty day moving average is $127.58 and its 200 day moving average is $120.98. Integer has a twelve month low of $73.40 and a twelve month high of $133.53. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.
Insider Activity at Integer
In other news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares of the company’s stock, valued at $272,824.80. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 2.00% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
Read Our Latest Research Report on Integer
Integer Company Profile
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Articles
- Five stocks we like better than Integer
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Stock Average Calculator
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- How to Invest in the FAANG Stocks
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.